Recombinant Nipah Virus Post-Fusion Glycoprotein (NIV pF) 抗体
Our Local Distributor
北京 101111
Quick Overview for Recombinant Nipah Virus Post-Fusion Glycoprotein (NIV pF) 抗体 (ABIN7824740)
抗原
抗体类型
适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
Expression System
- HEK293
-
原理
- Monoclonal Anti-Nipah Post Fusion glycoprotein Antibody, Human IgG1 (2B2) (MALS verified)
-
产品特性
- Monoclonal Anti-Nipah Post Fusion glycoprotein Antibody, Human IgG1 (2B2) is a chimeric monoclonal antibody recombinantly expressed from HEK293, which combines the variable region of a mouse monoclonal antibody with Human constant domain.
-
纯化方法
- Protein A purified / Protein G purified
-
纯度
- 95% as determined by SDS-PAGE.
-
过滤
- 0.22 μm filtered
-
亚型
- IgG1, kappa
-
-
-
-
应用备注
- ELISA: 0.03-31 ng/ml
-
限制
- 仅限研究用
-
-
-
状态
- Lyophilized
-
缓冲液
- Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.
-
注意事项
- Please avoid repeated freeze-thaw cycles.
-
储存条件
- -20 °C,-80 °C
-
储存方法
- For long term storage, the product should be stored at lyophilized state at -20°C or lower. This product is stable after storage at: -20°C to -70°C for 12 months in lyophilized state; -70°C for 3 months under sterile conditions after reconstitution.
-
-
- Nipah Virus Post-Fusion Glycoprotein (NIV pF)
-
别名
- Nipah Virus Post-Fusion Glycoprotein
-
背景
- Hendra virus (HeV) and Nipah virus (NiV) are henipaviruses discovered in the mid-to late 1990s that possess a broad host tropism and are known to cause severe and often fatal disease in both humans and animals. HeV and NiV infect host cells through the co
抗原
-